Flamicort 40mg/ml injection

Dexa Medica

Ingredients in every ml

Triamcinolone 40 mg

Each package contains

1 vial of 1 ml

Other details

Dosage form:Injection
Flavour: None

W.H.O. classification

ATC Level 1: H - Systemic hormonal preparations; excluding sex hormones and insulins
ATC Level 2: H02 - Corticosteroids for Systemic Use
ATC Level 3: H02A - Corticosteroids for Systemic Use; Plain



CONSULT YOUR DOCTORSafety of this item for use during pregnancy has not been established. Please consult your doctor.


CONSULT YOUR DOCTORSafety of this item for use during lactation has not been established. Please consult your doctor.


CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.


CONSULT YOUR DOCTORSafety of this item for use while operating heavy machinery has not been established. Please consult your doctor.

Available in


Dosage information

Initial dose: 60 mg.
Dosage is usually adjusted within the range of 40-80 mg, depending upon patient’s response and duration of relief.

Initial dose: 40 mg.
Dosage depends more on the severity of symptoms than on age or weight.

Insufficient clinical experience.

2.5 to 60 mg per day, depending on the specific disease entity being treated. In situations of less severity, lower doses will generally suffice while in selected patients higher initial doses may be required.

After a favorable response is noted, maintenance dosage must be determined by decreasing the initial drug dosage in small increments at appropriate time intervals until the lowest dosage which will maintain an adequate clinical response is reached.


Where oral therapy is not feasible or is temporarily undesirable in the judgement of the physician, Flamicort injection 40 mg/ml is indicated for intramuscular use as follows:
1. Allergic diseases.
2. Rheumatic disorders
As adjunctive therapy for short-term administration (to tide the patient over an acute episode exacerbation) in: post-traumatic osteoarthritis, synovitis of osteoarthritis, rheumatoid arthritis, acute or sub-acute bursitis, epicondylitis, acute nonspecific tenosynovitis, acute gouty arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile rheumatoid arthritis.
3. Collagen diseases
During an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus, acute rheumatic carditis.
4. Dermatologic diseases
Pemphigus, severe erythema multiforme (Stevens-Johnson syndrome), exfoliative dermatitis, bullous dermatitis herpetiformis, severe seborrheic dermatitis, severe psoriasis.
5. Edematous state
To induce diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus.


The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions or all warnings or alerts. Please check with a physician if you have health questions or concerns about interactions or go to the appropriate government authority for a comprehensive list of medical warnings. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.

All of the content present on this website, including written text, photographs, videos, graphics, and other resources we might include (these will fall under the collective term of “website”), is meant to educate and should not be perceived as a substitution for professional medical advice, diagnosis or treatment. You should not resort to the website information to arrive at a diagnosis or treatment solution for your health problems or various medical conditions. It does not replace medical care, provided by a medical specialist. In the situation, you have specific symptoms and you might suspect that you are suffering from a medical problem, it is for the best to consult your physician.